@article{9266337b2b534df49261f19c83175afa,
title = "Text mining for biology - The way forward: Opinions from leading scientists",
abstract = "This article collects opinions from leading scientists about how text mining can provide better access to the biological literature, how the scientific community can help with this process, what the next steps are, and what role future BioCreative evaluations can play. The responses identify several broad themes, including the possibility of fusing literature and biological databases through text mining; the need for user interfaces tailored to different classes of users and supporting community-based annotation; the importance of scaling text mining technology and inserting it into larger workflows; and suggestions for additional challenge evaluations, new applications, and additional resources needed to make progress.",
author = "Altman, {Russ B.} and Bergman, {Casey M.} and Judith Blake and Christian Blaschke and Aaron Cohen and Frank Gannon and Les Grivell and Udo Hahn and William Hersh and Lynette Hirschman and Jensen, {Lars Juhl} and Martin Krallinger and Barend Mons and O'Donoghue, {Se{\'a}n I.} and Peitsch, {Manuel C.} and Dietrich Rebholz-Schuhmann and Hagit Shatkay and Alfonso Valencia",
note = "Funding Information: Authors are listed in alphabetical order. MK and AV were responsible for inviting contributors; LH assembled and edited the collection of opinions. LH, MK, and AV were responsible for the Conclusion section. The authors contributing opinions are RA, CMB, JB, CB, AC, FG, LS, UH, WH, LJJ, BM, SIO, MCP, DRS, and HS. The participation of LH (MITRE) was supported under National Science Foundation Grant II-0640153. Funding Information: Christian Blaschke's work was funded by Bioalma. Frank Gannon, Director General of SFI, declares that he has no competing interests; SFI as a funding agency supports work in a variety of groups that are active in the area of software development. Dr Gannon's research group has in the past been supported by Wyeth Pharmaceuticals. Dr Gannon is the founder of three companies in areas unrelated to this topic. Manuel Peitsch is listed as an inventor on a Novartis patent for the Ultralink (USPTO Patent Application #: 20060150087; Patent Title: Ultralink text analysis tool.) text analysis tool; his work has been supported by Novartis AG. Barend Mons' work was supported (in part) by the company Knewco. Funding Information: The BioCreative II challenge and workshop were sponsored by the Frontiers of Functional Genomics Programme of the European Science Foundation (ESF) and by Genoma Espana http://gen-es.org. This article has been published as part of Genome Biology Volume 9 Supplement 2, 2008: The BioCre-ative II - Critical Assessment for Information Extraction in Biology Challenge. The full contents of the supplement are available online at http:/ /genomebiology.com/supplements/9/S2.",
year = "2008",
month = sep,
day = "1",
doi = "10.1186/gb-2008-9-s2-s7",
language = "English (US)",
volume = "9",
journal = "Genome biology",
issn = "1474-7596",
publisher = "BioMed Central",
number = "SUPPL. 2",
}